Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates. Weinshenker BG Ann Intern Med. 2014 Mar 18; 160(6):JC5. PMID: 24638183. Abstract CommentRecommendBookmarkWatch